CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 33 enrolled
Drug / intervention
Arformoterol Tartrate Inhalation Solution +2 moredrug
Likely dose
Arformoterol Tartrate Inhalation Solution 15 microgramfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00571428
NCT00571428Phase 4Completed
CompareCT.gov

Modified-blind, Randomized, Multicenter, Single Dose, Two-way Crossover Study of Arformoterol Tartrate Inhalation Solution 15 Micrograms Twice A Day Versus 30 Micrograms Once A Day in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Sumitomo Pharma America, Inc.·interventional·Posted Dec 12, 2007·Updated Feb 22, 2012

In Brief

A Phase 4 clinical trial evaluating Arformoterol Tartrate Inhalation Solution and Placebo for Chronic Obstructive Pulmonary Disease. Completed, enrolled 33 participants across 4 sites.

Detailed Summary

To evaluate the efficacy and safety of arformoterol tartrate inhalation solution 30μg/4mL QD (two 15μg/2mL dosed in combination) over a 24-hour period compared to arformoterol tartrate inhalation solution 15μg/2 mL BID in subjects with COPD.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Obstructive Pulmonary Disease
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 12, 2007
Enrollment StartNov 1, 2007
Primary CompletionMar 1, 2008
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 18.6 years ago

Interventions

Arformoterol Tartrate Inhalation Solutiondrug

Nebulized arformoterol tartrate inhalation solution 15 microgram twice a day (BID)

Arformoterol Tartrate Inhalation Solutiondrug

Nebulized arformoterol tartrate inhalation solution 30 microgram once a day (QD)

Placebodrug

Placebo inhalation solution (citrate buffered 0.9% saline solution) once a day